Search Results - "Küchler, Nadja"

CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients by Zöphel, Sylvia, Küchler, Nadja, Jansky, Johanna, Hoxha, Cora, Schäfer, Gertrud, Weise, Julius J, Vialle, Joanne, Kaschek, Lea, Stopper, Gebhard, Eichler, Hermann, Yildiz, Daniela, Moter, Alina, Wendel, Philipp, Ullrich, Evelyn, Schormann, Claudia, Rixecker, Torben, Cetin, Onur, Neumann, Frank, Orth, Patrick, Bewarder, Moritz, Hoth, Markus, Thurner, Lorenz, Schwarz, Eva C

“…Assessing the prognosis of patients with aggressive non-Hodgkin B cell lymphoma mainly relies on a clinical risk score (IPI). Standard first-line therapies are…”
Get full text

Soft Synthetic Cells with Mobile Membrane Ligands for Ex Vivo Expansion of Therapy‐Relevant T Cell Phenotypes by Burgstaller, Anna, Piernitzki, Nils, Küchler, Nadja, Koch, Marcus, Kister, Thomas, Eichler, Hermann, Kraus, Tobias, Schwarz, Eva C., Dustin, Michael L., Lautenschläger, Franziska, Staufer, Oskar

“…The expansion of T cells ex vivo is crucial for effective immunotherapy but currently limited by a lack of expansion approaches that closely mimic in vivo T…”
Get full text

Interdependence of sequential cytotoxic T lymphocyte and natural killer cell cytotoxicity against melanoma cells by Friedmann, Kim S., Kaschek, Lea, Knörck, Arne, Cappello, Sabrina, Lünsmann, Niklas, Küchler, Nadja, Hoxha, Cora, Schäfer, Gertrud, Iden, Sandra, Bogeski, Ivan, Kummerow, Carsten, Schwarz, Eva C., Hoth, Markus

“…Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells recognize and eliminate cancer cells. However, immune evasion, downregulation of immune function by…”
Get full text